Livzon Pharmaceutical Group Inc. Schedules Board Meeting to Discuss 2025 Annual Results

Bulletin Express
03/02

Livzon Pharmaceutical Group Inc. 麗珠醫藥集團股份有限公司 has announced that its Board of Directors will convene on 24 March 2026. The meeting will focus on reviewing and approving the annual results for the financial year ended 31 December 2025, as well as considering a possible final dividend. Any additional business deemed necessary will also be addressed.

According to the announcement dated 2 March 2026, the Board of Livzon Pharmaceutical Group Inc. includes Executive Directors, Non-Executive Directors, an Employee Representative Director, and Independent Non-Executive Directors.

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10